EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors
BLADT, Friedhelm, FADEN, Bettina, PEHL, Ulrich, STIEBER, Frank, SCHADT, Oliver, BLAUKAT, Andree, FRIESE-HAMIM, Manja, KNUEHL, Christine, WILM, Claudia, FITTSCHEN, Claus, GRÄDLER, Ulrich, MEYRING, Michael, DORSCH, Dieter, JAEHRLING, Frank
Published in Clinical cancer research (01.06.2013)
Published in Clinical cancer research (01.06.2013)
Get full text
Journal Article
Abstract 2786: Identification and preclinical characterization of EMD 1204831 – A selective c-Met kinase inhibitor in clinical phase 1
Bladt, Friedhelm, Blaukat, Andree, Dorsch, Dieter, Fittschen, Claus, Friese-Hamim, Manja, Graedler, Ulrich, Knuehl, Christine, Meyring, Michael, Schadt, Oliver, Stieber, Frank
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Abstract 3622: Preclinical characterization of EMD1214063, a potent and highly selective inhibitor of the c-Met kinase in Phase I clinical trials
Bladt, Friedhelm, Blaukat, Andree, Dorsch, Dieter, Fittschen, Claus, Friese-Hamim, Manja, Graedler, Ulrich, Meyring, Michael, Rautenberg, Wilfried, Schadt, Oliver, Stieber, Frank
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Abstract 5777: EMD 1214063, an exquisitely selective c-Met kinase inhibitor in clinical phase 1
Schadt, Oliver, Bladt, Friedhelm, Blaukat, Andree, Dorsch, Dieter, Friese-Hamim, Manja, Fittschen, Claus, Graedler, Ulrich, Meyring, Michael, Rautenberg, Wilfried, Stieber, Frank, Wilm, Claudia
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Abstract B252: Identification of a new class of highly potent and selective c-Met kinase inhibitors
Blaukat, Andree, Bladt, Friedhelm, Dorsch, Dieter, Fittschen, Claus, Friese-Hamim, Manja, Graedler, Ulrich, Meyring, Michael, Rautenberg, Wilfried, Schadt, Oliver, Stieber, Frank
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
PHENYLALAMINE DERIVATIVES AS INTEGRIN INHIBITORS
WIESNER MATTHIAS, FITTSCHEN CLAUS, GOODMAN SIMON, RADDATZ PETER, MERZ JOACHIM, ANZALI SOHEILA, DIEFENBACH BEATE
Year of Publication 25.04.2000
Get full text
Year of Publication 25.04.2000
Patent
CHROMENONE AND CHROMANONE DERIVATIVES AS INTEGRIN INHIBITORS
WIESNER, MATTHIAS, GOODMAN, SIMON, RADDATZ, PETER, MARZ, JOACHIM, FITTSCHEN, CLAUS
Year of Publication 29.09.2009
Get full text
Year of Publication 29.09.2009
Patent
CHROMENON- UND CHROMANONDERIVATE ALS INTEGRINHEMMER
MAERZ, JOACHIM, WIESNER, MATTHIAS, GOODMAN, SIMON, RADDATZ, PETER, FITTSCHEN, CLAUS
Year of Publication 15.09.2007
Get full text
Year of Publication 15.09.2007
Patent
CHROMENONE AND CHROMANONE DERIVATIVES AS INTEGRIN INHIBITORS
MAERZ, JOACHIM, WIESNER, MATTHIAS, GOODMAN, SIMON, RADDATZ, PETER, FITTSCHEN, CLAUS
Year of Publication 22.08.2007
Get full text
Year of Publication 22.08.2007
Patent